Healthcare Innovation Forum: Fostering Innovation and Creativity in Vietnam's Healthcare Sector
Healthcare Innovation Forum: Fostering Innovation and Creativity in Vietnam's Healthcare Sector - Express Healthcare Management The Healthcare Innovation Forum, hosted by Pharma Group, brought together over 400 attendees to discuss the importance of innovation and creativity in Vietnam's healthcare sector. The forum highlighted the National Strategy for developing Vietnam’s pharmaceutical industry, which aims to enhance production, distribution, circulation, and the quality of drugs. Speakers discussed new approaches such as strengthening research capacity, facilitating clinical trials, and leveraging advanced technologies like AI and data management. Dr. Nguyen Lan Hieu, director of Hanoi Medical University Hospital, believes that innovation will continue to play a significant role in medical development in Vietnam. As the voice of the pharmaceutical industry in Vietnam, Pharma Group and its member companies aim to ensure fast and sustainable access to safe, high-quality, and innovative medicines.
Diterbitkan : 2 tahun lalu oleh Sandeep Kunchikor di dalam Health
The recent Healthcare Innovation Forum, hosted by Pharma Group, brought together over 400 attendees, including scientists, doctors, policymakers, and businesses. This event, attended by notable figures such as Deputy Minister of Health Assoc. Prof. Nguyen Thi Lien Huong, Ambassador of the European Union to Vietnam Julien Guerrier, and Ambassador of Ireland to Vietnam Deirdre Ni Fhalluin, aimed to contribute significantly to the development of Vietnam’s pharmaceutical industry.
During the forum, Huong highlighted the National Strategy for developing Vietnam’s pharmaceutical industry, which aims to enhance production, distribution, circulation, and the quality of drugs. The strategy also focuses on domestically produced brand-name drugs, new dosage forms, and bio medicines. Additionally, efforts are being made to establish a digital data ecosystem and health platform to optimize drug supply activities and patient usage.
Speakers at the forum provided valuable insights into research, innovations, and knowledge-sharing. Attendees explored new approaches such as strengthening research capacity, facilitating clinical trials, and leveraging advanced technologies like AI and data management. The forum also emphasized the importance of attracting investments and creating a favorable legal environment to support scientific research and technology transfer.
Dr. Emin Turan, chairman of Pharma Group, highlighted Vietnam’s potential to become a hub for science and innovation in healthcare. He emphasized the need for enhancing research and development capabilities, implementing digital transformation, and creating a sustainable policy climate to support innovation.
Experts at the forum emphasized the importance of innovation and creativity in Vietnam’s healthcare sector. They stressed that these factors bring numerous benefits, including improved quality of care, increased access to services, optimized resource management, and advancements in medical research. To foster a vibrant and resilient healthcare sector, experts recommended strengthening research and development, establishing a diverse healthcare ecosystem, and promoting partnerships and solution-oriented approaches.
Dr. Nguyen Lan Hieu, director of Hanoi Medical University Hospital, shared how innovative solutions have directly impacted the healthcare industry. The application of remote healthcare and monitoring devices, as well as digitalization of medical records, has improved convenience for patients, doctors, and hospitals. Dr. Hieu believes that innovation will continue to play a significant role in medical development in Vietnam.
The Healthcare Innovation Forum not only celebrated Pharma Group’s 25th anniversary but also highlighted its commitment to supporting Vietnam’s healthcare sector. As the voice of the pharmaceutical industry in Vietnam, Pharma Group and its member companies aim to ensure fast and sustainable access to safe, high-quality, and innovative medicines.
Source: This article is based on the main points of a source article.
Topik: Vietnam